INVEST IN UKRAINE. Pharmaceutics

Life Elixir: how a pharmaceutical company launched the production of infusions

And why is it unique for Ukraine.

Medical investment: where Ukrainian pharmacy needs support

What factors can attract foreign capital into the industry

The story of recovery: how the Ukrainian pharmaceutical market is getting over the crisis

For the first time in four years, sales growth in monetary terms has been recorded

General director of pharmaceutical firm “Darnitsa”: “Import substitution is nothing more than another form of competition”

Svitlana Didenko speaks about market realities, public interests, patients’ preferences and the company’s readiness for the healthcare reform